Verazinc
(Zinc sulfate)Phase 3Small molecule
Zinc sulfate is used to treat zinc deficiency in the body, which can occur from poor nutrition, certain medical conditions, or as a supplement to help with wound healing and immune function.[1] Verazinc is currently being investigated across 14 indications[3], with its most advanced program in Phase 3.[1]
Verazinc is one of 198 small molecule programs targeting Chronic Periodontitis. It is currently in Phase 3.
14
Indications
32
Total Trials
4
Active Trials
197
Competitors
Pipeline
Status by Indication[3][1]
Indication
Showing 10 of 14 indications
Competition
Competitive Landscape
242 competitors in Efficacy and Safety
#DrugCompanyPhaseTrials
1Verazinc
FFakultas Kedokteran Universitas Indonesia
Phase 3
Lutathera
NovartisPhase 3
HLX10
Shanghai Henlius BiotechPhase 3
PLB1004
AAvistone Biotechnology Co., Ltd.
Phase 3
NTQ5082
NNanjing Chia-tai Tianqing Pharmaceutical
Phase 3
HSK39297
Haisco Pharmaceutical Group Co., Ltd.Phase 3
KN057
SSuzhou Alphamab Co., Ltd.
Phase 3
IN-B00009
HHK inno.N Corporation
Phase 3
AVTX-803
AAUG Therapeutics
Phase 3
DFL24498
DDompé Farmaceutici S.p.A
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Acute Diarrhea3 trials
Oral Zinc for the Treatment of Acute Diarrhea in US Children
Completed·—·N/A·NCT01198587·71 enrolled
Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
Unknown status·—·Phase 2·NCT01140074·256 enrolled
Sepsis2 trials
Anemia2 trials
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
Completed·—·Phase 2/3·NCT04301336·350 enrolled
Low Birth Weight2 trials
Vaccine1 trial
Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
Completed·—·N/A·NCT01229579·320 enrolled
22 more indications
Cutaneous Warts1 trial
Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts
Unknown status·—·Phase 3·NCT03158168·70 enrolled
Type 2 Diabetic Patients1 trial
The Effect of Zinc on the Gingival Crevicular Fluid Level of Total Oxidant Capacity in Type 2 Diabetic Patients
Unknown status·—·N/A·NCT03923829·34 enrolled
Hyperbilirubinemia1 trial
Randomised Controlled Trial1 trial
Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial
Completed·ZZekai Tahir Burak Women's Health Research and Education Hospital·Phase 4·NCT05311540·195 enrolled
Jaundice1 trial
Critically Ill1 trial
Oral Mucositis1 trial
Hematological Malignancies1 trial
Acceptability1 trial
Zinc Sulfate Acceptability
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·N/A·NCT04039828·325 enrolled
Chemoradiotherapy1 trial
Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations
Completed·—·Phase 3·NCT03824925·70 enrolled
Effectiveness1 trial
Atorvastatin1 trial
Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients
Unknown status·—·Phase 2·NCT05395143·92 enrolled
Hepatitis1 trial
Efficacy and Safety1 trial
COVID-191 trial
Neonatal1 trial
Unspecified1 trial
The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia
Unknown status·—·Phase 1·NCT05178953·160 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Zinc sulfate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details